Network

Mainz is a life science and biotechnology hub with a diversified and powerful ecosystem. Mainz and the surrounding region are in excellent shape, boasting strong players and major companies from the life sciences and biotechnology industry (such as Boehringer Ingelheim, Merck, Sanofi, BioNTech and Schott). Other life science and biotechnology companies, as well as suppliers, are also located in the vicinity and contribute significantly to the growth of the industry.

Educational and research facilities create a sound knowledge base and make a significant contribution to economic prosperity. Nine partnership-focused research facilities, eight hospitals and two universities with a first-class reputation drive interdisciplinary research in the field of life sciences and related research and special research fields in the area.

Two of seven finalists in the second round of the Clusters4Future competition funded by the German Federal Ministry of Education and Research — the Cluster for Atherothrombosis and Individualized Medicine (curATime) initiative and the Electrifying Technical Organic Syntheses (ETOS) network — are based in Mainz and play a major role, demonstrating the excellent work of local researchers and their outstanding connections to each other.

The Mainz Research Alliance has represented the broad-based, high-standard research and technological expertise in and around Mainz since 2008.

The Association for Cancer Immunotherapy (CIMT) is a member-based organization that facilitates the knowledge exchange between academic and industry scientists, physicians and regulatory authorities who research and develop cancer immunotherapies. Every year, the CIMT organizes the largest and most influential international cancer immunotherapy meeting in Europe.

On behalf of the state capital Mainz, we support the establishment of an internationally recognized biotechnology & life science platform in Rhineland-Palatinate.

Biotechnology is a highly dynamic field of research. There is great potential when different disciplines work together, and research and industry form a network.

To strengthen activities, the state government of Rhineland-Palatinate is setting up a new platform for biotechnology and life sciences in close cooperation with the state capital Mainz.

With the development of the state-wide platform and close networking of the biotechnology players, existing companies are consolidated, spin-offs are accelerated and the business and innovation location is strengthened overall.

More information can be found here.